Strength
750 mg/1
Manufacturer
AvPAKNDC
50268055115
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
METFORMIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078321On Market Since
5/2/2022
Pharmacological Classes
Price Statistics
The NADAC for METFORMIN HCL ER 750 MG TABLET has been published 202 times since Aug 17, 2022, and over the history we have for it it has declined 24.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0548 per EA |
|---|---|
| All-time high | $0.0769 (Mar 15, 2023) |
| All-time low | $0.0526 (Sep 17, 2025) |
| 52-week high | $0.0566 |
| 52-week low | $0.0526 |
| Median price | $0.0617 |
| Average price | $0.0617 |
| Largest weekly change | +24.7% (Feb 22, 2023) |
| Weeks tracked | 202 |
| Tracking since | Aug 17, 2022 |
Generic Alternatives
The matcher finds 9 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 9 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of METFORMIN HCL ER 750 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METFORMIN HCL ER 750 MG TABLET, manufactured by AvPAK, is $0.0548 per EA (NDC 50268055115), effective Jun 24, 2026.
How has the price of METFORMIN HCL ER 750 MG TABLET changed over time?
Over the history we have for it, the NADAC for METFORMIN HCL ER 750 MG TABLET has declined 24.5%. It has been tracked across 202 weekly CMS publications since Aug 17, 2022.
What are the highest and lowest recorded NADAC prices for METFORMIN HCL ER 750 MG TABLET?
Since Aug 17, 2022, the NADAC for METFORMIN HCL ER 750 MG TABLET has ranged from a low of $0.0526 (Sep 17, 2025) to a high of $0.0769 (Mar 15, 2023), with a median of $0.0617 per EA.
Are there cheaper alternatives to METFORMIN HCL ER 750 MG TABLET?
Yes. 9 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, METFORMIN HCL ER 750 MG TABLET, is $0.0546 per EA — about 0% below METFORMIN HCL ER 750 MG TABLET.
Who manufactures METFORMIN HCL ER 750 MG TABLET?
METFORMIN HCL ER 750 MG TABLET (NDC 50268055115) is labeled by AvPAK, and CMS classifies it as a generic product.
Related Drugs
Same classification